Last week HCS Pharma was pleased to take part to Elrig Uk Research & Innovation. This event took place on the 20 and 21 March in Manchester. It was a great opportunity to share another time our technology with the scientific community of Elrig. We enjoy the program mixing a Read more…
RIKEN, equivalent to CNRS in France, is a national research and development agency based in Japan and is the largest comprehensive research institution in the country. After RIKEN symposium held in Belgium on February 14 where Dr Nathalie Maubon, our CEO, and Dr Meryl Roudaut, our stem cell and liver Read more…
During this time of celebrating the Chinese New Year, HCS Pharma extends its best wishes to all those observing this special occasion. This year, the transition to the Year of the Dragon promises to bring strength, courage, and growth opportunities. We take this opportunity to thank our partners, clients, and Read more…
A great way to ended the year 2023! The participation of Dr. Nathalie MAUBON and Dr. Meryl ROUDAUT to represent HCS Pharma at HACKOSAKA event in december 2023 in Japan was an excellent opportunity to once again promote the results of research with our extracellular matrix 3Dmodel, BIOMIMESYS.We are honored Read more…
HCS Pharma start the year 2024 with a brand new strength! The new laboratories are welcome to continue to satisfy medical researchers and receive more and more demand from all around the world for our physiological and biological matrix BIOMIMESYS®. May our new premises be the theatre of more collaboration Read more…
HCS Pharma wishes you an excellent year 2024 full of rebound, laughter, joy, and innovation! As the clocks mark the passage of time, a wave of optimism fills the minds. Technological advances, scientific discoveries and commitments to sustainability promise of a bright future. Communities come together to address global challenges, Read more…
Once again this year, the Cosmetic 360 trade show lived up to its promise ! Numerous beauty and health professionals including HCS Pharma were present on October 18th and 19th in Paris. Services, finished products or ingredients, essential oils, the latest trends and innovative ideas were all there to delight Read more…
Nathalie Maubon CEO of HCS Pharma will be alongside with our longtime partner Molecular Devices in Taiwan on the 5th of October. This event as always is designed by Molecular Devices to inspire, educate, and connect scientists, researchers, and professionals in the field. We thank our partner Molecular Devices for Read more…
BIOMIMESYS® has taken place in the panel of the future medicine on the 27th of September. The next step has arrived, and Nathalie Maubon CEO of HCS Pharma has taken BIOMIMESYS® all the way to Asia. Our innovative and reliable 3D cell culture system is adapted to high throughput formats Read more…
The great meeting for the cosmetic field “Cosmetic 360” is back again ! Oceane GUYOT our project manager in dermocosmetology and Rita HIEN our business developper will be at this event on the 18th/19th and are looking forward to see you there. Do not hesitate to solicit us if you Read more…
HCS Pharma is speeding up its expansion into Asia ! Our CEO/CSO Mme. Nathalie MAUBON will again be in Asia and speak for the first time in China ! Mme. MAUBON will deliver a speech at Shanghai Zhangjiang Life Science International Innovation Summit on the 27th September and participate in Read more…
Find out more about BIOMIMESYS® and its wide range of applications (oncology, neurosciences, metabolism, adipocyte research) in this informative article. A comprehensive article describing the benefits of our products and the importance of results in research projects. For any question about our products, please feel free to contact us at Read more…
Positive thinking = positive living ! Welcome back to work ! HCS Pharma wishes you a safe return to work and stay available to advice you about how our breaktrough 3D technologies BIOMIMESYS® declined for multiple specific research field can make your return to work smoother. Do not hesitate to Read more…
The Perseid meteor shower which is taking place on the 14th of July and will finish on the 1st September will reach its high point between the 10 and the 14th of August. Debris from comet Swift-Tuttle, which has broken off from its tail, is falling and should end its Read more…
Our BIOMIMESYS® Adipose tissue extracellular matrix expands our 3D study possibilities ! HCS Pharma offers you a new 3D test for the evaluation of slimming properties of your actives ingredients. It offers you the possibility to observe the fat-inhibiting potential of your compounds. Adipose tissue is mainly composed of mature Read more…
Follow the webinar « From 2D to 3D » with miss Oceane Guyot, R&D dermarto cosmetology Project leader on ; – Tuesday, April 25, 2023 – 9AM (CEST) / 3PM (CST) / 4PM (JST) / 3AM (EST) – Thursday, April 27, 2023 – 5PM (CEST) / 11PM (CST) / 12PM (JST) / 11AM Read more…
We will be pleased to meet you in Paris from the 28th to 30th of March. Join Thierry DE CATHEU Business Director, Mathieu LAOUENAN Chief Commercial Officer, Paul COUVREUR and Rita HIEN Junior Business Developpers. Meryl Roudaut, our Project leader in metabolic tissues, and our Project director Elodie VANDENHAUTE will Read more…
Welcome to HCS Pharma series of webinars and please register for free to the ones you want to attend. You will receive the specific Zoom link within a week prior the event.You will learn more about BIOMIMESYS®, an amazing and disruptive technology that reproduces all aspects of the microenvironment (matrix Read more…